COUGH is the #16 most commonly reported adverse reaction for ACETAMINOPHEN 325 MG, manufactured by Ulai Health LLC. There are 3 FDA adverse event reports linking ACETAMINOPHEN 325 MG to COUGH. This represents approximately 1.4% of all 211 adverse event reports for this drug.
Patients taking ACETAMINOPHEN 325 MG who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH3 of 211 reports
COUGH is a less commonly reported adverse event for ACETAMINOPHEN 325 MG, but still significant enough to appear in the safety profile.
Other Side Effects of ACETAMINOPHEN 325 MG
In addition to cough, the following adverse reactions have been reported for ACETAMINOPHEN 325 MG:
COUGH has been reported as an adverse event in 3 FDA reports for ACETAMINOPHEN 325 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with ACETAMINOPHEN 325 MG?
COUGH accounts for approximately 1.4% of all adverse event reports for ACETAMINOPHEN 325 MG, making it a notable side effect.
What should I do if I experience COUGH while taking ACETAMINOPHEN 325 MG?
If you experience cough while taking ACETAMINOPHEN 325 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.